Today's Market

Why are stocks up (or down) and what does the latest Nvidia news mean? Today’s Market will answer those questions and keep you informed about big stock market movers. We’ll also tell you about the latest Fed moves, what stocks Warren Buffett is buying, and which stocks look primed for a short squeeze. Today’s Market is the perfect pairing of InvestorPlace’s expert financial advice and critical stock and crypto news.

Top Stories

Market News

AMC Stock Soars 15% as Meme Trading Heats Up

AMC stock is trading higher following the release of Q2 earnings and the announcement of an APE special dividend.

2 Analysts Upgrade FSLR Stock on Inflation Reduction Act Passage

First Solar is in the news today as FSLR stock may be the biggest beneficiary of the Senate-passed Inflation Reduction Act.

Is Helbiz (HLBZ) Stock the Next Big Meme Stock?

Today, investors in Helbiz and HLBZ stock woke up to an incredible move. Shares are surging triple digits on essentially no news.

WazirX Facing Money Laundering Accusations and Drama With Binance

WazirX is receiving a one-two punch of bad news today as it faces a money laundering probe and a very public spat with Binance.

Why Is GameStop (GME) Stock Rocketing Higher Today?

Today's price action across a broad basket of meme stocks, including GME stock, has investors wondering if this is the start of another rally.

NVDA Stock Falls 7% on Warnings of Q2 Revenue Miss

Nvidia disclosed preliminary results for its upcoming second-quarter report which badly disappointed analysts, boding poorly for NVDA stock.

What Is Going on With Bonso Electronics (BNSO) Stock Today?

Bonso Electronics (BNSO) stock is rocketing higher on Monday alongside heavy trading despite a lack of news from the company.

Why Is Clovis Oncology (CLVS) Stock Down 10% Today?

Clovis Oncology is in the red today after a lackluster earnings report. CLVS stock is down 10% on missed profit and revenue.

TBLT, RDBX: The Top 5 Short Squeeze Stocks to Watch This Week

Short squeeze stocks are still a hot topic this week and we're listing five of the shares investors will want to keep an eye on!

Dear TSLA Stock Fans, Mark Your Calendars for Aug. 17

Shares of TSLA stock are in the green after the company announced Aug. 17 as its date of record for the upcoming 3-for-1 stock split.

Why Are Hydrogen Stocks FCEL, BE, GEVO, PLUG Up Today?

Each of these hydrogen stocks has its own target market, so their performance under the Inflation Reduction Act will vary.

Stellar Lumens Price Predictions: Where Will Robinhood Take the XLM Crypto?

XLM is on the minds of traders today as it joins Robinhood. That has investors checking out the latest Stellar Lumens price predictions.

GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics

GBT stock is already rallying on takeover talk. Now that Pfizer has confirmed the buyout, Global Blood Therapeutics is red hot.

Avalanche Price Predictions: Where Will Robinhood Take the AVAX Crypto?

Avalanche (AVAX) price predictions are worth diving into today with news of the crypto being added to Robinhood (HOOD) pushing it higher!

Signify Health (SGFY) Stock Jumps 15% on CVS Takeover Rumors

Even though a potential CVS buyout of Signify Health hasn't been confirmed by the two companies, SGFY stock is nonetheless heading higher.

Magic Empire Global (MEGL) Stock Continues to Squeeze Higher

Magic Empire Global had just $2.1 million in revenue last year. MEGL stock had a market cap of roughly $3 billion as of Aug. 8, however.

What Is Going on With Palantir (PLTR) Stock Today?

Shares of Palantir are down 14% today after the data analytics firm reported earnings that disappointed analysts and investors.

Ethereum Price Predictions: Where Will the ETH Crypto Go Next?

Ethereum (ETH) price predictions are worth checking on today as the crypto trends across social media with investors preparing for the Merge.

Karuna Therapeutics (KRTX) Stock Soars 64% on Positive Clinical Data

Karuna Therapeutics (KRTX) stock is rocketing higher on Monday thanks to results from a Phase 3 EMERGENT-2 trial to treat schizophrenia.